Tiziana Life Sciences PLC Sponsored ADR Stock price
Is Tiziana Life Sciences PLC Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,134 stocks worldwide.
Key metrics
Tiziana Life Sciences PLC Sponsored ADR Stock Analysis
Analyst Opinions
7 Analysts have issued a Tiziana Life Sciences PLC Sponsored ADR forecast:
Analyst Opinions
7 Analysts have issued a Tiziana Life Sciences PLC Sponsored ADR forecast:
Don't miss a Thing! We will send you all news about Tiziana Life Sciences PLC Sponsored ADR directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Tiziana Life Sciences PLC Sponsored ADR Stock News
Company Profile
Tiziana Life Sciences Plc is a biotechnology company, which engages in the research and development of biotechnological and pharmaceutical products. Its lead product candidate in immunology is Foralumab (TZLS-401), which is a fully human anti-CD3 monoclonal antibody. The company was founded by Gabriele Marco Antonio Cerrone on November 4, 2013 and is headquartered in London, the United Kingdom.
| Head office | United Kingdom |
| CEO | Mr. Elrifi |
| Employees | 10 |
| Founded | 1998 |
| Website | www.tizianalifesciences.com |


